SILO PHARMA, INC. Peo Total Comp Amt
SILO PHARMA, INC. (SILO) reported Peo Total Comp Amt of $521.75 thousand for the 12-month period ending 2025-12-31, per its DEF 14A filed 2026-06-30.
Financial Statements › Notes
ecd:PeoTotalCompAmt · last filed 2026-06-30
| Period end | Peo Total Comp Amt 12 month |
|---|---|
| 2025-12-31 | $521.75K DEF 14A · filed 2026-06-30 |
| 2024-12-31 | $630.05K DEF 14A · filed 2026-06-30 |
| 2023-12-31 | $569.01K DEF 14A · filed 2026-06-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |